Prelude Therapeutics Inc (PRLD) › Shareholders' EquityPrelude Therapeutics Inc (PRLD) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$22.69M2019: -$49.41M2020: $212.18M2021: $285.90M2022: $195.44M2023: $237.09M2024: $131.46M2025: $68.64M$68.64M2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$68.64M-47.8%2024$131.46M-44.6%2023$237.09M+21.3%2022$195.44M-31.6%2021$285.90M+34.7%2020$212.18M+529.4%2019-$49.41M-117.7%2018-$22.69M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share